High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
Spremljeno u:
| Glavni autori: | , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2020-10-01
|
| Serija: | Annals of Intensive Care |
| Online pristup: | http://link.springer.com/article/10.1186/s13613-020-00758-5 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|
